José Antonio García Erce: Which Oral Iron Therapy Should We Choose?
José Antonio García Erce, Vocal-elect of the Board of the Spanish Society of Hematology and Hemotherapy, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Clinical Medicine, adding:
“We are honoured to have published this review with Drs. Santiago García Lopez and Antonio Martínez-Francés in a special issue of Journal of Clinical Medicine (JCM) MDPI: Special Issue Clinical Updates in Transfusion Medicine and Patient Blood Management) open to receive more papers.
Our thanks to Dr Salvador Payán-Pernía for his thorough professional critique which has been instrumental in improving this work”
Title: Iron Deficiency and Oral Treatments: Limitations, Pharmacokinetics, and the Role of Iron Protein Succinylate in Clinical Practice
Authors: José Antonio García-Erce, Santiago García-López, Antonio Martínez-Francés
Other posts featuring José Antonio García Erce on Hemostasis Today.
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation